DarioHealth director receives 54,000-share award

The 2024 conversion was subject to a non-waivable 19.99% ownership blocker under the preferred stock's conversion terms.

Rhea-AI Filing Summary

DarioHealth Corp. director Yoav Shaked received a 54,000-share restricted share award on September 24, 2026. The award vests in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date, over two years.

On August 12, 2024, his 40 Series B-2 preferred shares automatically converted into 15,431 common shares, subsequently reported as 772 shares following a reverse stock split. Including dividend shares, Shaked beneficially owned 33,582 common shares immediately after the conversion.

Insider Trade Summary

40 shares exercised/converted

Exercise 4 txns

Insider Shaked Yoav

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F3	54,000	$0.00	$0.00
Conversion	Series B-2 Preferred Stock	40	$1,000.00	$40K
Conversion	Common Stock F1, F2	772	$19.10	$15K
holding	Common Stock F4	--	--	--

Holdings After Transaction: Series B-2 Preferred Stock — 0 contracts (Direct); Common Stock — 87,582 shares (Direct); Common Stock — 84 shares (Indirect, By spouse)

Footnotes (4)

1. F1. Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.
2. F2. The Reporting Person's 40 shares of Series B-2 Preferred Stock automatically converted into 15,431 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 772 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 33,582 shares of Common Stock immediately following the conversion.
3. F3. The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.
4. F4. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Key Figures

Restricted share award: 54,000 shares Vesting installments: 8 equal quarterly installments Vesting period: 2 years +5 more

8 metrics

Restricted share award 54,000 shares Granted September 24, 2026

Vesting installments 8 equal quarterly installments Restricted share award

Vesting period 2 years Restricted share award

Series B-2 preferred shares converted 40 shares August 12, 2024

Common shares from conversion 15,431 shares August 12, 2024 conversion

Conversion shares reported after reverse stock split 772 shares Following a subsequent reverse stock split

Common shares beneficially owned after conversion 33,582 shares Immediately following the conversion, including dividend shares

Non-waivable ownership blocker 19.99% Preferred stock conversion limitation

Key Terms

restricted share award, beneficial ownership limitations, non-waivable 19.99% ownership blocker, reverse stock split

4 terms

restricted share award financial

"The restricted share award shall vest in eight equal quarterly installments"

A restricted share award is a grant of company stock given to an employee or executive that only becomes permanent ownership if certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of it as a gift locked in a box that opens when the rules are satisfied; for investors, these awards can dilute existing shares and signal management’s incentives and confidence in future performance.

beneficial ownership limitations regulatory

"subject to certain beneficial ownership limitations"

Beneficial ownership limitations are rules or contractual caps that restrict how much of a company’s stock an individual or entity can be treated as owning or controlling for legal, regulatory or corporate-governance purposes. They matter to investors because such limits affect voting power, reporting obligations, takeover risk and the ability to increase a stake — like an elevator weight limit or a lane divider that prevents any one car from taking over the whole road.

non-waivable 19.99% ownership blocker regulatory

"including a non-waivable 19.99% ownership blocker"

reverse stock split financial

"Following the Issuer's subsequent reverse stock split"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares were included in Yoav Shaked's DRIO award?

Yoav Shaked received a 54,000-share restricted share award on September 24, 2026. It vests in eight equal quarterly installments on the last day of each successive calendar quarter after grant, over two years.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 04:07 PM Accepted by SEC EDGAR 09/28/2026 - 04:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shaked Yoav

(Last) (First) (Middle)

322 W 57TH STREET, #33B

(Street)

NEW YORK NEW YORK 10019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DarioHealth Corp. [ DRIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2024

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2024(1)		C		772(2)	A	$19.1(2)	33,582(2)	D
Common Stock	09/24/2026(3)		A		54,000	A	$0	87,582	D
Common Stock								84(4)	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B-2 Preferred Stock	$1,000	08/12/2024		C			40	05/04/2023	08/04/2024	Common Stock	772	$1,000	0	D

Explanation of Responses:

1. Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date.

2. The Reporting Person's 40 shares of Series B-2 Preferred Stock automatically converted into 15,431 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 772 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 33,582 shares of Common Stock immediately following the conversion.

3. The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period.

4. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

	/s/ Yoav Shaked	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)